Kraig Biocraft Laboratories (KBLB) Cash from Financing Activities (2010 - 2025)

Kraig Biocraft Laboratories (KBLB) has 16 years of Cash from Financing Activities data on file, last reported at $602198.0 in Q4 2025.

• For the quarter ending Q4 2025, Cash from Financing Activities changed N/A year-over-year to $602198.0; the trailing twelve-month figure through Dec 2025 stood at $2.5 million (up 7102.33% YoY), and the FY2025 full-year result was $2.5 million, up 7102.33% from the prior year.
• Cash from Financing Activities eased to $602198.0 in Q4 2025, from $1.0 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $3.3 million in Q2 2021 to a low of -$15000.0 in Q3 2022.
• A 5-year average of $508360.6 and a median of -$5244.0 in 2024 frame the typical range for Cash from Financing Activities.
• Across the five-year window, Cash from Financing Activities tumbled 120.33% in 2022 and jumped 19538.12% in 2025, its largest moves.
• Tracing KBLB's Cash from Financing Activities over 5 years: stood at $73774.0 in 2021, then plunged by 120.33% to -$15000.0 in 2022, then changed by 0.0% to -$15000.0 in 2023, then jumped by 65.04% to -$5244.0 in 2024, then surged by 11583.56% to $602198.0 in 2025.
• Business Quant data shows KBLB's Cash from Financing Activities at $602198.0 in Q4 2025, $1.0 million in Q3 2025, and $688131.0 in Q2 2025.